Skip to main content
. 2009 Jan;16(1):16–26. doi: 10.3747/co.v16i1.361

FIGURE 5.

FIGURE 5

Treatment recommendations for rash mediated by monoclonal antibody (mAb) targeting of epidermal growth factor receptor, by severity. (Adapted from the BC Cancer Agency’s egfr inhibitors rash protocol.) o.d. = once daily; b.i.d. = twice daily.